BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 22158553)

  • 1. Novel molecular therapies for heritable skin disorders.
    Uitto J; Christiano AM; McLean WH; McGrath JA
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):820-8. PubMed ID: 22158553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-based therapies for epidermolysis bullosa - from bench to bedside.
    Uitto J; Has C; Bruckner-Tuderman L
    J Dtsch Dermatol Ges; 2012 Nov; 10(11):803-7. PubMed ID: 23107326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular therapeutics for heritable skin diseases.
    Uitto J
    J Invest Dermatol; 2012 Nov; 132(E1):E29-34. PubMed ID: 23154630
    [No Abstract]   [Full Text] [Related]  

  • 4. Progress in heritable skin diseases: translational implications of mutation analysis and prospects of molecular therapies*.
    Uitto J
    Acta Derm Venereol; 2009; 89(3):228-35. PubMed ID: 19479117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progress in molecular genetics of heritable skin diseases: the paradigms of epidermolysis bullosa and pseudoxanthoma elasticum.
    Uitto J; Pulkkinen L; Ringpfeil F
    J Investig Dermatol Symp Proc; 2002 Dec; 7(1):6-16. PubMed ID: 12518787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revertant mosaicism in skin: natural gene therapy.
    Lai-Cheong JE; McGrath JA; Uitto J
    Trends Mol Med; 2011 Mar; 17(3):140-8. PubMed ID: 21195026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular therapies for heritable blistering diseases.
    Tamai K; Kaneda Y; Uitto J
    Trends Mol Med; 2009 Jul; 15(7):285-92. PubMed ID: 19581127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem Cell Therapy for Epidermolysis Bullosa-Does It Work?
    Tamai K; Uitto J
    J Invest Dermatol; 2016 Nov; 136(11):2119-2121. PubMed ID: 27772543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-based prenatal diagnosis of heritable skin diseases.
    Christiano AM; Uitto J
    Arch Dermatol; 1993 Nov; 129(11):1455-9. PubMed ID: 7902070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratin gene mutations in disorders of human skin and its appendages.
    Chamcheu JC; Siddiqui IA; Syed DN; Adhami VM; Liovic M; Mukhtar H
    Arch Biochem Biophys; 2011 Apr; 508(2):123-37. PubMed ID: 21176769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in epidermolysis bullosa: from eponyms to molecular genetic classification.
    Uitto J; Richard G
    Clin Dermatol; 2005; 23(1):33-40. PubMed ID: 15708287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward Combined Cell and Gene Therapy for Genodermatoses.
    De Rosa L; Latella MC; Secone Seconetti A; Cattelani C; Bauer JW; Bondanza S; De Luca M
    Cold Spring Harb Perspect Biol; 2020 May; 12(5):. PubMed ID: 31653644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EB2017-Progress in Epidermolysis Bullosa Research toward Treatment and Cure.
    Uitto J; Bruckner-Tuderman L; McGrath JA; Riedl R; Robinson C
    J Invest Dermatol; 2018 May; 138(5):1010-1016. PubMed ID: 29391251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathology of the basement membrane zone in heritable blistering diseases:: The paradigm of epidermolysis bullosa.
    Uitto J; Has C; Vahidnezhad H; Youssefian L; Bruckner-Tuderman L
    Matrix Biol; 2017 Jan; 57-58():76-85. PubMed ID: 27496350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The genodermatoses: candidate diseases for gene therapy.
    Uitto J; Pulkkinen L
    Hum Gene Ther; 2000 Nov; 11(16):2267-75. PubMed ID: 11084685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular genetics of heritable blistering disorders.
    Uitto J; Pulkkinen L
    Arch Dermatol; 2001 Nov; 137(11):1458-61. PubMed ID: 11708948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Context-Dependent Strategies for Enhanced Genome Editing of Genodermatoses.
    March OP; Kocher T; Koller U
    Cells; 2020 Jan; 9(1):. PubMed ID: 31906492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise.
    Chamcheu JC; Wood GS; Siddiqui IA; Syed DN; Adhami VM; Teng JM; Mukhtar H
    Exp Dermatol; 2012 Jul; 21(7):481-9. PubMed ID: 22716242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene editing for skin diseases: designer nucleases as tools for gene therapy of skin fragility disorders.
    March OP; Reichelt J; Koller U
    Exp Physiol; 2018 Apr; 103(4):449-455. PubMed ID: 28271571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interpretation of genomic sequence variants in heritable skin diseases: A primer for clinicians.
    Uitto J; Saeidian AH; Youssefian L; Vahidnezhad H
    J Am Acad Dermatol; 2023 Sep; 89(3):569-576. PubMed ID: 34118299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.